Ampersand Capital Partners
Private equity
Active
Wellesley, United States
72
10M
55
2.06
24
0.24
27
- Stages of investment
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Wellesley. The fund was located in North America if to be more exact in United States.
The higher amount of exits for fund were in 2017. The fund is constantly included in 2-6 investment rounds annually. The average startup value when the investment from Ampersand Capital Partners is 100-500 millions dollars. The real fund results show that this VC is 25 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Ampersand Capital Partners works on 6 percentage points more the average amount of lead investments. The important activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight FirstRain, Endeca, Ensemble Communications. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Life Science, Medical. The fund has exact preference in a number of founders of portfolio startups.
This organization was formed by Richard A. Charpie. We also calculated 11 valuable employees in our database.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Ampersand Capital Partners, startups are often financed by Diamondhead Ventures, Venrock, Star Ventures. The meaningful sponsors for the fund in investment in the same round are Diamondhead Ventures, Venrock, Oak Investment Partners. In the next rounds fund is usually obtained by Oak Investment Partners, Venrock, GGV Capital.
Investor highlights
- Industry focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 72
- Lead investments
- 24
- Exits
- 27
- Rounds per year
- 2.06
- Follow on index
- 0.24
- Investments by industry
- Biotechnology (32)
- Health Care (20)
- Pharmaceutical (15)
- Manufacturing (14)
- Medical (11) Show 34 more
- Investments by region
-
- United States (62)
- Australia (2)
- United Kingdom (1)
- Netherlands (1)
- Germany (3) Show 2 more
- Peak activity year
- 2019
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 56M
- Group Appearance index
- 0.43
- Avg. company exit year
- 13
- Avg. multiplicator
- 7.92
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| AnaBios | 07 Jun 2022 | Media and Information Services (B2B), Biotechnology, Drug Discovery, Pharmaceuticals, Medical, Pharmaceutical | Late Stage Venture | 6M | United States, California, San Diego |
| Endeca | 06 Feb 2002 | E-Commerce, Software, Enterprise Software, Search Engine | Late Stage Venture | 16M | United States, Cambridge, Massachusetts |
| FineMEMS | 25 Sep 2015 | Enterprise, Manufacturing, Electronics | Early Stage Venture | 0 | Hubei, Jiang'an District, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.